DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cr74f5/north_america) has announced the addition of the "North America Orthobiologics Market Outlook to 2020" report to their offering.
"North America Orthobiologics Market Outlook to 2020", provides key market data on the North America Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.
- Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the North America Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc., Stryker Corporation and Alphatec Holdings, Inc.
Key Topics Covered:
1 Tables & Figures
3 Orthobiologics Market, North America
4 Orthobiologics Market, Canada
5 Orthobiologics Market, Mexico
6 Orthobiologics Market, United States
7 Overview of Key Companies in North America Orthobiologics Market
8 Orthobiologics Market Pipeline Products
9 Financial Deals Landscape
10 Recent Developments